Impact of extremely low-frequency electromagnetic field (100 Hz, 100 G) exposure on human glioblastoma U87 cells during Temozolomide administration
Glioblastoma multiforme (GBM) is a highly malignant brain tumor with an extremely dismal prognosis, a median survival is12 months. Temozolomide (TMZ) is an alkylating agent widely used to treat cancer, resistance to this drug is often found. One unexplored possibility for overcoming this resistance...
Saved in:
Published in | Electromagnetic biology and medicine Vol. 38; no. 3; pp. 198 - 209 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
03.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!